Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Comparing the Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on Plasma Levels of CoQ10 (SPARQ)

NCT01660191 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT01660191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01660191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Comparing the Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on Plasma Levels of CoQ10 (SPARQ)
Lead sponsor
University of Kansas Medical Center
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
October 31, 2013
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia